Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Form 8 (Opening Position Disclosure)

15 Jan 2026 11:23

RNS Number : 0907P
PhillipCapital UK Limited
15 January 2026
 

FORM 8 (OPD)

 

AMENDED DISCLOSURE - PLEASE REFER TO SECTION 3

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

CORRECTION

 

Amendment - this form replaces RNS number 7034K published at 16:00 on 8 December 2025. Changes made to section 3.

 

1. KEY INFORMATION

 

(a) Full name of discloser:

PhillipCapital UK Ltd ("PhillipCapital")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Walker Crips Group Plc ("Walker Crips")

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

5 December 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

6 2/3 pence Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

35,000

0.08

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

35,000

0.08

Nil

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Name

Number of Walker Crips relevant securities held

Percentage of Walker Crips relevant securities held

Ms Bee Tin Chua*

611,574

1.43%

Linus Wen Sheong Lim

3,496,694

8.21%

Mr Lim Wen Yao Lloyd*

3,496,694

8.21%

Mr Wen Jiang Luke Lim*

3,496,692

8.21%

Madam Lay Cheng Ng*

611,574

1.43%

Ms Beng Lian Janice See*

611,575

1.43%

Mr Lim Wah Tiong*

300,000

0.70%

 

*Close relative of Lim Hua Min (member of the Board of PhillipCapital UK Ltd)

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

15 January 2026

Contact name:

Linus Lim

Telephone number:

+65 8163 8247

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBBGDBLBBDGLU
Date   Source Headline
25th Nov 20257:00 amRNSForm 8.3 - Walker Crips Group PLC
24th Nov 20257:47 amRNSDisclosure Table
24th Nov 20257:00 amRNSRecommended Cash Offer for Walker Crips Group PLC
24th Nov 20257:00 amRNSWorking Capital Loan Extension & Trading Update
29th Sep 20255:04 pmRNSResult of AGM
3rd Sep 20255:45 pmRNSDirectorate Change
14th Aug 20255:30 pmRNSDirectorate Change
31st Jul 20255:45 pmRNSWorking Capital Loan Drawdown Facility
31st Jul 20255:45 pmRNSFinal Results
9th Jul 20251:15 pmRNSBoard and Management Changes
28th Apr 20255:45 pmRNSAppointment of Non-Executive Director
7th Apr 202510:36 amRNSDirector Declaration
31st Mar 20255:45 pmRNSAppointment of Non-Executive Chairman
12th Feb 20254:32 pmRNSDirector Declaration
6th Feb 20255:45 pmRNSDirectorate Changes
27th Dec 20249:45 amRNSResults for the six months ended 30 September 2024
27th Nov 20247:30 amRNSDirector/PDMR Shareholding
27th Sep 202412:00 pmRNSResult of AGM
31st Jul 20241:00 pmRNSFinal results for the year ended 31 March 2024
14th Jun 202410:01 amRNSResignation of Non-executive Director
28th Dec 202312:15 pmRNSResults for the six months ended 30 September 2023
27th Sep 20232:07 pmRNSResult of AGM
31st Jul 20236:25 pmRNSFinal results for the year ended 31 March 2023
23rd Dec 202210:00 amRNSHalf-year Report
11th Oct 20225:19 pmRNSDirector/PDMR Shareholding
29th Sep 20221:37 pmRNSResult of AGM
29th Jul 20223:01 pmRNSFinal Results
9th Jun 20223:28 pmRNSHolding(s) in Company
26th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Mar 20223:25 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSHalf-year Report
28th Sep 20211:12 pmRNSResult of AGM
16th Sep 20219:06 amRNSSecond Price Monitoring Extn
16th Sep 20219:00 amRNSPrice Monitoring Extension
20th Aug 20213:40 pmRNSFinal Results
28th Jan 20215:39 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 202112:03 pmRNSDirector/PDMR Shareholding
22nd Dec 20203:00 pmRNSExternal Auditor Appointment
27th Nov 20209:34 amRNSHalf-year Report - Replacement
27th Nov 20207:00 amRNSHalf-year Report
28th Oct 20209:24 amRNSDirector/PDMR Shareholding
2nd Oct 20203:55 pmRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20205:57 pmRNSDirector/PDMR Shareholding - Replacement
18th Sep 20204:48 pmRNSDirector/PDMR Shareholding
11th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 202012:30 pmRNSResult of AGM
19th Aug 202012:25 pmRNSDirector/PDMR Shareholding
4th Aug 20202:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.